Axiom Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Axiom Investment Management's LLY Position: Q2 2026 in Review
Axiom Investment Management reduced its Eli Lilly (LLY) stake by 0.78% in Q2 2026, selling an estimated $11.2K and leaving 1,400 shares worth $1.68M. The position accounts for 1.12% of the portfolio, ranked #21.
Axiom Investment Management first reported a position in LLY in Q4 2018 and has held it in 15 quarters since. The position peaked at $5.36M in Q1 2019. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Axiom Investment Management held 1,400 shares of Eli Lilly worth $1.68M as of Q2 2026.
- Axiom Investment Management sold 11 Eli Lilly shares in Q2 2026, an estimated $11.2K.
- Eli Lilly made up 1.12% of Axiom Investment Management's portfolio in Q2 2026, its #21 holding.
- Axiom Investment Management first reported a position in Eli Lilly in Q4 2018 and has held it in 15 quarters since.
- Axiom Investment Management's Eli Lilly position peaked at $5.36M in Q1 2019.
- 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Axiom Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.